Categories: BrainHealthcareNews

The Siegel Rare Neuroimmune Association Creates First-Ever Online Micro-Course for People With Rare Neuroimmune Disorders

The online learning program reflects organization’s dedication to empowering individuals and families affected by these conditions with knowledge and support

POWELL, OH / ACCESSWIRE / June 20, 2024 / The Siegel Rare Neuroimmune Association (SRNA) has released several new courses as part of its unique online learning program. This innovative educational series provides a comprehensive understanding of rare neuroimmune disorders. Every course includes content developed with medical experts.

The program:

  • Improves knowledge and health literacy about rare neuroimmune disorders among individuals and/or their care partners impacted by these conditions.
  • Reduces uncertainty about the diagnoses by educating individuals about diagnostic tools and management.
  • Provides resources to help people have a meaningful discussion with their healthcare practitioner about their diagnosis and advocate for the best care.

The first course, “Understanding Rare Neuroimmune Disorders,” was released in February. Participants learn about the immune system, the nervous system, and the similarities and differences between each disorder.

Additional courses each focus on one condition – acute disseminated encephalomyelitis (ADEM), acute flaccid myelitis (AFM), MOG antibody disease (MOGAD), neuromyelitis optica spectrum disorder (NMOSD), optic neuritis (ON), and transverse myelitis (TM). These in-depth courses answer questions including:

  • What is the disorder?
  • What symptoms are present at onset?
  • Who is most likely to be affected by the disorder?
  • How is the disorder acutely treated?
  • What is the prognosis for those living with the disorder?

Each course features videos with helpful animations, written text, and knowledge checks. The courses are accessible via screen reader for those who are blind or have low vision.

The courses are for SRNA members. Membership is free and opens the door to a wealth of information, support, and education.

Understanding rare neuroimmune disorders

In rare neuroimmune disorders, a person’s immune system mistakenly attacks the brain, spinal cord and/or optic nerves. These disorders have devastating lifelong impacts and often cause permanent complications like difficulty breathing, depression, vision loss, persistent pain, and paralysis. They can affect individuals of any age. People who are diagnosed have no warning this life-changing event will happen. These disorders can relapse so people may face this crisis multiple times. Progress has been made in diagnosing and treating these disorders, but no cure exists.

“We have learned from our community interactions that educating individuals impacted by rare neuroimmune disorders about the different diagnoses is key for better management and long-term care,” says Executive Director Chitra Krishnan.

This year is SRNA’s 30th anniversary, and SRNA encourages people to learn more about rare neuroimmune disorders and their lifelong impact. Visit the SRNA website and Facebook, LinkedIn and Instagram for 30th-anniversary education, advocacy events, and information.

# # #

The Siegel Rare Neuroimmune Association is a non-profit organization dedicated to the support of people with acute disseminated encephalomyelitis, acute flaccid myelitis, MOG antibody disease, neuromyelitis optica spectrum disorder, optic neuritis, and transverse myelitis. Our goal is to improve the quality of life of individuals with these rare neuroimmune disorders. Visit our website to learn more.

Contact Information

GG deFiebre, PhD
info@wearesrna.org
855-380-3330

SOURCE: Siegel Rare Neuroimmune Association

View the original press release on newswire.com.

View the original press release on accesswire.com

Staff

Recent Posts

The State of HTM, 2025: Report Signals Changing Health Tech Workforce

Biomedical Engineers, Clinical Engineers, Others Weigh in on State of the Health Care IndustryArlington, Virginia--(Newsfile…

27 minutes ago

Standard Process Launches Cultivate, a New Practitioner Symposium Advancing Whole-Food Nutrition and Healthy Aging

Two immersive 2026 events in Seattle and Boston will offer up to 12 CE credits,…

1 hour ago

Vericel Announces Preliminary 2025 Financial Results and Business Updates

Total Revenue Expected to be $276 Million  MACI Revenue Expected to be $239.5 Million Fourth…

1 hour ago

Stroke Experts Challenge “90-Day Recovery” Myth: New Research Shows Patients Need Long-Term Care

Study published by Centre for Neuro Skills researchers in Brain Injury journal argues current insurance…

1 hour ago

Femasys Announces Partnership with Refuah Health Center to Expand First-Line Access to FemaSeed® in Community-Based Care

Partnership enables broader adoption of FemaSeed through a trusted community health provider serving a large,…

1 hour ago

IMDX Supports AST and ASHI STAR Working Group’s Call for Decentralized Transplant Monitoring

American Journal of Transplantation position paper also highlights value of absolute quantification of dd-cfDNA as…

1 hour ago